Paliperidone Tablet, Extended Release
Product Images NDC 70518-4267

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Paliperidone (NDC 70518-4267). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mm1 (Paliperidone 9mg 70518 4267 00)

Mm1 (Paliperidone 9mg 70518 4267 00)
This is a description of Paliperidone Extended-Release tablets with a strength of 9 mg. The tablets come in a quantity of 30 and should be swallowed whole without dividing, crushing, or chewing. They need to be protected from moisture and are prescription-only medication. It includes the NDC number, manufacturing information, storage instructions, and a disclaimer to keep out of reach of children. The directions for use can be found in the package insert, and the medication should be stored at 20-25°C (58-77°F) with excursions permitted up to 15.30°C (59-86°F) according to USP standards. The tablets are repackaged by Remedy Repack Inc. in Indiana.*
FDA Label Image

Mm2 (Paliperidone 9mg 70518 4267 01)

Mm2 (Paliperidone 9mg 70518 4267 01)
This is a box of Paliperidone Extended-Release tablets contains 30 tablets, each with a strength of 9 mg. The tablets are meant to be swallowed whole and should not be divided, crushed, or chewed. It is important to protect the tablets from moisture. The medication is prescription-only and the NDC number is 70518-4267-01. The manufacturer is Sun Pharma located in Cranbury, NJ. The medication should be stored at 20-25°C (58-77°F) with excursions permitted to 15.30°C (59-86°F). Ensure to keep this medication out of the reach of children. Detailed directions for use can be found in the package insert.*
FDA Label Image

Mm3 (Paliperidone 9mg 70518 4267 02)

Mm3 (Paliperidone 9mg 70518 4267 02)
This is a description of a Paliperidone 9mg Extended-Release tablet. The tablet should be swallowed whole and not divided, crushed, or chewed. It should be protected from moisture. The medication is prescribed as per the doctor's recommendation, and the packaging includes information about NDC, expiration date, lot number, and manufacturer details. It is advised to keep the medication out of reach of children and to store it at a temperature between 20-25°C (58-77°F) with excursions permitted to 15-30°C (59-86°F) as per USP standards. For detailed usage instructions, refer to the package insert. The medication has been repackaged by RemedyRepack inc., Indiana, PA 15701.*
FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.